At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1 enrolled
Drug / intervention
Pancreatic Duct Stent Placement +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Trial Examining the Impact of Pancreatic Duct Stent Placement in Patients With Acute Necrotizing Pancreatitis in the Prevention of Walled-off Necrosis
In Brief
A clinical study evaluating Pancreatic Duct Stent Placement and No Pancreatic Duct Stent Placement for Necrotizing Pancreatitis and Walled Off Necrosis. Completed, enrolled 1 participant across 1 site.
Detailed Summary
The research design is a randomized prospective clinical study comparing the incidence of Walled Off Necrosis (WON) in patients with acute necrotizing pancreatitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNecrotizing Pancreatitis, Walled Off Necrosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartAug 2016
First PostedApr 2017
Primary CompletionJul 2020
Study CompletionNov 2020
TodayJul 2026
First PostedApr 14, 2017
Enrollment StartAug 4, 2016
Primary CompletionJul 1, 2020
Study CompletionNov 3, 2020
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 9.2 years ago
Interventions
Pancreatic Duct Stent Placementdevice
Patients will be randomly allocated to either treatment arm to have a PD stent placed.
No Pancreatic Duct Stent Placementother
Patients will be randomly allocated to either treatment arm and not receive PD placement.